In addition, as a competitive inhibitor of the mitochondrial complex III, ATV can significantly affect the oxidative phosphorylation of cancer cells to change the hypoxic environment of tumor cells and greatly improve the efficacy of various clinical treatment methods. This evidence concerns the gene NBN and cancer.